Loading
Latest filing published 16 Mar 2023 for Pangenomic Health Inc., €1.2M.
No signal scores available.
Mydecine Innovations Group Inc. appears in our data through filings on Pangenomic Health Inc. shares, published by SEDI. We count 2 filings; the first trade dates from 9 December 2022 and the latest from 2 January 2023.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 16 March 2023 with a transaction (€1.2M) in Pangenomic Health Inc. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations